Everolimus clinical trials mTOR inhibitor

Certican - Afinitor - RAD001 - RAD 001 - 40-O-(2-hydroxyethyl)-rapamycin - SDZ-RAD - SDZ RAD

Recap Results Trial description old Pinterest treatment           Z

Advanced breast cancer (metastatic)

All type of patients:  3 trials  - BOLERO-3 - TAMRAD - BOLERO-2

HR+ HER2-:  2 trials  - TAMRAD - BOLERO-2

Patient trastuzumab-resistant, and previously treated by taxanes:  1 trials  - BOLERO-3

Patients recurring or progressing after prior endocrine therapy :  2 trials  - TAMRAD - BOLERO-2

Renal-cell carcinoma (advanced)

2 trials  - RECORD 3 - RECORD-1